Trials / Completed
CompletedNCT01893567
Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05%
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to investigate the utility of a technological based rating scale for assessing improvement in plaque psoriasis with Clobex spray treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clobex Spray |
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2013-10-01
- Completion
- 2013-10-01
- First posted
- 2013-07-09
- Last updated
- 2022-09-27
- Results posted
- 2014-07-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01893567. Inclusion in this directory is not an endorsement.